Related Experiment Video
Updated: Apr 5, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Screening for diabetes in patients receiving second-generation atypical antipsychotics
April Hinds1, Lois Coulter2, Jonell Hudson2
1April Hinds, Pharm.D., is Postgraduate Year 1 (PGY1) Pharmacy Resident; Lois Coulter, Pharm.D., BCPS, is Associate Professor and PGY1 Pharmacy Residency Director; Jonell Hudson, Pharm.D., BCPS, is Associate Professor; and Victoria Seaton, Pharm.D., is Assistant Professor, University of Arkansas for Medical Sciences Northwest, Fayetteville. april.hinds@austin.utexas.edu.
Purpose:
Results of a study to assess adherence with a consensus statement for diabetes screening in patients receiving atypical antipsychotics and to evaluate the role of pharmacists in a patient-centered medical home in improving guideline adherence are presented.
Summary:
For patients prescribed atypical antipsychotics, records were reviewed for glycosylated hemoglobin (HbA1c) testing within the past 12 months. If no HbA1c results were found within that time frame, physicians were sent an alert in the patient's electronic medical record requesting an HbA1c order. Patient medical records were reviewed to analyze the number of HbA1c orders before and after pharmacist intervention. Prior to pharmacist intervention, 17 of 120 (14%) patients were screened with HbA1c. As a result of pharmacist intervention, 86 alerts were sent to physicians to order an HbA1c level, 24 (28%) of which included an order for an HbA1c level. Eleven of 24 (46%) HbA1c test results were collected during study follow-up, and one prediabetic patient was identified.
Conclusion:
After pharmacist intervention, a greater number of patients receiving atypical antipsychotic medications had HbA1c levels monitored for evidence of type 2 diabetes.
More Related Videos
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
Psychosis and Antipsychotic Drugs: Overview
Diabetes: Symptoms, Diagnosis, and Complications
Antipsychotic Drugs: Typical and Atypical Agents
Oral Hypoglycemic Agents: Sulfonylureas